# Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

> **NCT07562932** · NA · NOT_YET_RECRUITING · sponsor: **Chonnam National University Hospital** · enrollment: 512 (estimated)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DRUG:** Norepinephrine
- **DRUG:** Dopamine Agent

## Key facts

- **NCT ID:** NCT07562932
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-31
- **Primary completion:** 2031-05-31
- **Final completion:** 2032-05-31
- **Target enrollment:** 512 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07562932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07562932, "Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT07562932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*